Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
4.540
+0.340 (8.10%)
At close: Jul 31, 2026, 4:00 PM EDT
4.490
-0.050 (-1.10%)
After-hours: Jul 31, 2026, 7:59 PM EDT
Tilray Brands Revenue
In the fiscal year ending May 31, 2026, Tilray Brands had annual revenue of $915.45M with 11.46% growth. Tilray Brands had revenue of $281.71M in the quarter ending May 31, 2026, with 25.47% growth.
Revenue (ttm)
$915.45M
Revenue Growth
+11.46%
P/S Ratio
0.67
Revenue / Employee
$322,116
Employees
2,842
Market Cap
615.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2026 | 915.45M | 94.15M | 11.46% |
| May 31, 2025 | 821.31M | 32.37M | 4.10% |
| May 31, 2024 | 788.94M | 161.82M | 25.80% |
| May 31, 2023 | 627.12M | -1.25M | -0.20% |
| May 31, 2022 | 628.37M | 115.29M | 22.47% |
| May 31, 2021 | 513.09M | 302.60M | 143.77% |
| Dec 31, 2020 | 210.48M | -194.84M | -48.07% |
| May 31, 2020 | 405.33M | 238.35M | 142.74% |
| Dec 31, 2019 | 166.98M | 123.85M | 287.15% |
| Dec 31, 2018 | 43.13M | 22.59M | 110.00% |
| Dec 31, 2017 | 20.54M | 7.89M | 62.43% |
| Dec 31, 2016 | 12.64M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evotec SE | 859.03M |
| Pacira BioSciences | 734.86M |
| Amphastar Pharmaceuticals | 720.53M |
| Emergent BioSolutions | 676.80M |
| Ironwood Pharmaceuticals | 361.51M |
| Evolus | 301.79M |
| Canopy Growth | 203.89M |
| Kamada | 181.68M |
TLRY News
- 2 days ago - Tilray Brands stock continues its downward spiral: buy the dip or sell the rip? - Invezz
- 3 days ago - 3 Canadian Marijuana Stocks Can Make You Big Gains - MarijuanaStocks
- 4 days ago - Tilray Brands Earnings Call Transcript: Q4 2026 - Transcripts
- 4 days ago - Tilray Brands Earnings release: Q4 2026 - Filings
- 4 days ago - Tilray Brands Annual report: Q4 2026 - Filings
- 4 days ago - Tilray Brands Registration statement: Q4 2026 - Filings
- 4 days ago - Tilray Brands Registration statement: Q4 2026 - Filings
- 4 days ago - Tilray Brands Delivers Record Fiscal 2026 Revenue and Adjusted EBITDA; Demonstrating the Strength of its Diversified Global Platform Across Cannabis, Beverage, Hospitality and Wellness - GlobeNewsWire